Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Minerva Endocrinologica|March 1, 1993
[Essential obesity: an unresolved clinical problem. Considerations on central appetite stimulants and inhibitors]M Lamberto, M Mantovan, R F NoviMinerva Endocrinologica|October 1, 1989
[Sipple's syndrome. Review of the literature and personal case load]M Lamberto, R F Novi, M Porta, et al.Panminerva Medica|January 1, 1989
Reductions of body weight and blood pressure in obese hypertensive patients treated by diet. A retrospective studyR F Novi, M Porta, M Lamberto, et al.Minerva Endocrinologica|March 4, 1999
[Increased body mass index increase and insulin resistance parameters in dyslipidemia. Risk and positive correlation in essential obesity]G Alberto, R F Novi, M Maurino, et al.Minerva Gastroenterologica E Dietologica|February 18, 2006
[Management of overweight and obese patient. New acquisition]R F Novi, E Scalabrino, M A Seardo, et al.Acta Endocrinologica|October 1, 1980
Effect of sulpiride on plasma prolactin levels in women with puerperal or pathological hyperprolactinaemiaF Massara, F Camanni, L Belforte, et al.Journal of Endocrinological Investigation|February 1, 1983
Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutismM Messina, C Manieri, P Biffignandi, et al.European Journal of Pharmacology|January 5, 2002
Apomorphine, dopamine and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate 1A Chiarenza, M Scarselli, F Novi, et al.Obesity Research|May 18, 2005
Down-regulation of pyruvate dehydrogenase phosphatase in obese subjects is a defect that signals insulin resistanceMarco Piccinini, Michael Mostert, Gianfrancesco Alberto, et al.Minerva Gastroenterologica E Dietologica|February 24, 2006
[Management of obese patients: surgical therapy]M Toppino, R F Novi, E Scalabrino, et al.Pageof 2